Andrew Delgado
About Andrew Delgado
Andrew Delgado is a Field HEOR Scientist at Bristol Myers Squibb, with a background in pharmacy management, clinical pharmacy, and health economics research. He holds a PhD in Pharmaceutical Sciences and a PharmD from The University of Texas at Austin.
Current Title and Company
Andrew Delgado currently holds the position of Field HEOR Scientist, Southwest at Bristol Myers Squibb. In this role, he contributes to health economics and outcomes research, focusing on the Southwest region.
Previous Roles and Experience
Andrew Delgado has accumulated extensive experience in the field of pharmacy and health economics. He served as a Pharmacy Manager at Cardinal Health in San Antonio, Texas, from 2019 to 2020. Before that, he worked as a Clinical Pharmacist at Metropolitan Methodist Hospital in San Antonio from 2018 to 2019, and also held the same position at the same hospital's Live Oak, Texas location from 2014 to 2018. Delgado was an Associate Research Pharmacist at Precision Health Economics in Austin, Texas, from 2015 to 2017.
Academic Background and Education
Andrew Delgado has a robust educational background, having studied at The University of Texas at Austin. He earned a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from 2014 to 2019 and a Doctor of Pharmacy (PharmD) from 2010 to 2014 at the College of Pharmacy. Additionally, he holds a Bachelor of Science (BS) degree in Human Biology, which he completed from 2006 to 2010.
Research Contributions
Andrew Delgado has made significant contributions to the field of health economics outcomes research. He has published a research paper in a peer-reviewed journal and presented his findings on healthcare cost-effectiveness at the ISPOR conference. His work has led to the development of a new health economic model that is currently used by healthcare providers in the Southwest region.
Achievements and Awards
Among his notable achievements, Andrew Delgado was awarded the 'Outstanding Researcher Award' from the University of Texas at Austin for his contributions to pharmaceutical sciences. Furthermore, he has served as a mentor for graduate students in health economics and outcomes research.